Close

Jazz Pharmaceuticals (JAZZ) Cutting PT on Higher OpEx - Mizuho

August 10, 2016 6:19 AM EDT Send to a Friend
Mizuho Securities analyst, Irena Koffler, reiterated her Buy rating on shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) but reduced her ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login